Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma, Ewing × Diphosphonates × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Neoplasm Metastasis 2 Sarcoma, Ewing 1 Osteoporotic Fractures 1 Osteoporosis 1 Musculoskeletal Pain 1 Multiple Myeloma 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Arthralgia 1

Interventions

Cyclophosphamide 15 Temozolomide 12 Vincristine 9 Irinotecan 8 Melphalan 7 Doxorubicin 7 Topotecan 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 Etoposide 5 Drug Therapy 5 liposomal doxorubicin 4 fludarabine 4 cabozantinib 4 Sirolimus 4 Ifosfamide 4 Filgrastim 4 pegfilgrastim 3 fludarabine phosphate 3 Zoledronic Acid 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Cisplatin 3 Bone Marrow Transplantation 3 regorafenib 2 pegylated granulocyte colony-stimulating factor 2 olaparib 2 irinotecan sucrosofate 2 ganitumab 2 Vinorelbine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00987636 2019-10-22

EWING2008

University Hospital Muenster

Phase 3 Completed

Neoplasm Metastasis, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡